These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 21052001

  • 1. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples.
    De Miglio MR, Mura A, Uras MG, Manca A, Contini M, Murgia L, Zinellu A, Sotgia S, Carru C, Massarelli G, Cossu-Rocca P.
    Diagn Mol Pathol; 2010 Dec; 19(4):201-8. PubMed ID: 21052001
    [Abstract] [Full Text] [Related]

  • 2. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS, Er TK, Lu HC, Yeh KT, Chang JG.
    Clin Chim Acta; 2014 Sep 25; 436():169-75. PubMed ID: 24863805
    [Abstract] [Full Text] [Related]

  • 3. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W, Ye F, Tran V, Yang Z, White R, Bloom K, Choppa P, Labourier E.
    J Clin Pathol; 2011 Jan 25; 64(1):30-6. PubMed ID: 21030527
    [Abstract] [Full Text] [Related]

  • 4. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ, Lee SE, Kang SY, Choi YL.
    Pathol Res Pract; 2011 Dec 15; 207(12):762-8. PubMed ID: 22070922
    [Abstract] [Full Text] [Related]

  • 5. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
    Ausch C, Buxhofer-Ausch V, Oberkanins C, Holzer B, Minai-Pour M, Jahn S, Dandachi N, Zeillinger R, Kriegshäuser G.
    J Mol Diagn; 2009 Nov 15; 11(6):508-13. PubMed ID: 19797612
    [Abstract] [Full Text] [Related]

  • 6. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L.
    Magy Onkol; 2010 Dec 15; 54(4):383-94. PubMed ID: 21163770
    [Abstract] [Full Text] [Related]

  • 7. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
    Okayama N, Nishioka M, Hazama S, Sakai K, Suehiro Y, Maekawa M, Sakamoto J, Iwamoto S, Kato T, Mishima H, Oka M, Hinoda Y.
    Jpn J Clin Oncol; 2011 Feb 15; 41(2):165-71. PubMed ID: 20926413
    [Abstract] [Full Text] [Related]

  • 8. [High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer].
    Fukushima Y, Yanaka S, Murakami K, Abe Y, Koshizaka T, Hara H, Samejima C, Kishi Y, Kaneda M, Yoshino T.
    Gan To Kagaku Ryoho; 2011 Nov 15; 38(11):1825-35. PubMed ID: 22083191
    [Abstract] [Full Text] [Related]

  • 9. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC, Grebe SK.
    Clin Chim Acta; 2013 Oct 21; 425():1-2. PubMed ID: 23832066
    [Abstract] [Full Text] [Related]

  • 10. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
    Harlé A, Busser B, Rouyer M, Harter V, Genin P, Leroux A, Merlin JL.
    Virchows Arch; 2013 Mar 21; 462(3):329-35. PubMed ID: 23400679
    [Abstract] [Full Text] [Related]

  • 11. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
    Lee S, Brophy VH, Cao J, Velez M, Hoeppner C, Soviero S, Lawrence HJ.
    Virchows Arch; 2012 Feb 21; 460(2):141-9. PubMed ID: 22173329
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K, Walsh R, Brilliant K, Noble L, Yakirevich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P.
    Exp Mol Pathol; 2013 Aug 21; 95(1):74-82. PubMed ID: 23528430
    [Abstract] [Full Text] [Related]

  • 13. A comparability study of 5 commercial KRAS tests.
    Oliner K, Juan T, Suggs S, Wolf M, Sarosi I, Freeman DJ, Gyuris T, Baron W, Bakker A, Parker A, Patterson SD.
    Diagn Pathol; 2010 Apr 16; 5():23. PubMed ID: 20398393
    [Abstract] [Full Text] [Related]

  • 14. Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.
    Carotenuto P, Roma C, Rachiglio AM, Tatangelo F, Pinto C, Ciardiello F, Nappi O, Iaffaioli RV, Botti G, Normanno N.
    Pharmacogenomics; 2010 Aug 16; 11(8):1169-79. PubMed ID: 20712532
    [Abstract] [Full Text] [Related]

  • 15. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B, Florence C, Kamel R, Nadia K, Ines O, Raja M, Sarra BJ, Florent S, Amel BA.
    Cancer Biomark; 2010 Aug 16; 8(6):331-40. PubMed ID: 22072121
    [Abstract] [Full Text] [Related]

  • 16. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
    Lamy A, Blanchard F, Le Pessot F, Sesboüé R, Di Fiore F, Bossut J, Fiant E, Frébourg T, Sabourin JC.
    Mod Pathol; 2011 Aug 16; 24(8):1090-100. PubMed ID: 21516079
    [Abstract] [Full Text] [Related]

  • 17. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
    Seekhuntod S, Thavarungkul P, Chaichanawongsaroj N.
    PLoS One; 2016 Aug 16; 11(1):e0147672. PubMed ID: 26812617
    [Abstract] [Full Text] [Related]

  • 18. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Aug 16; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 19. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P, Roma C, Cozzolino S, Fenizia F, Rachiglio AM, Tatangelo F, Iannaccone A, Baron L, Botti G, Normanno N.
    Int J Oncol; 2012 Feb 16; 40(2):378-84. PubMed ID: 21971641
    [Abstract] [Full Text] [Related]

  • 20. KRAS and BRAF mutation analysis from liquid-based cytology brushings of colorectal carcinoma in comparison with formalin-fixed, paraffin-embedded tissue.
    Spathis A, Georgoulakis J, Foukas P, Kefala M, Leventakos K, Machairas A, Panayiotides I, Karakitsos P.
    Anticancer Res; 2010 Jun 16; 30(6):1969-75. PubMed ID: 20651341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.